V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208924 | 20175879 | 1.77 | 60 | Curative (C) | 2019-01-02 | 2019-01-26 | Bevacizumab + Irinotecan + MdG | 02 | N | NERATINIB | 101629550 |
| 20210629 | 20175882 | 1.65 | 48 | 03 | 2021-12-09 | 2022-01-15 | Hepatoblastoma HR Carbo/Dox | 02 | N | GEMCARBO | 101794725 |
| 20210893 | 20175883 | 1.65 | 64.3 | null | 2021-06-05 | 2021-06-12 | VINORELBINE | 02 | null | ATEZOLIZUMAB | 101295603 |
| 20210918 | 20175884 | 1.75 | null | Palliative (P) | 2016-10-18 | 2016-10-18 | ACTICCA-1 Trial | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100555649 |
| 20211333 | 20175885 | null | null | 03 | 2018-10-01 | 2018-10-24 | Bevacizumab + Irinotecan + MdG | 02 | N | IRINOTECAN + RALTITREXED | 101221870 |
| 20211578 | 20175886 | 1.75 | 7.8 | Palliative (P) | 2021-06-16 | 2021-07-17 | BCG Intravesical | N | N | CAPITAL TRIAL | 100774675 |
| 20211673 | 20175887 | null | null | 03 | 2018-09-22 | 2018-10-12 | Brentuximab | 02 | null | TOPOTECAN | 100408345 |
| 20213191 | 20175890 | 1.71 | 14.6 | Palliative (P) | 2021-12-20 | 2021-12-21 | Triple Intrathecal | 02 | null | SCOPE2 TRIAL | 101484197 |
| 20214103 | 20175891 | 1.65 | null | null | 2016-10-10 | 2017-03-14 | DA | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100473129 |
| 20214585 | 20175892 | 0 | 59.9 | Curative (C) | 2018-08-25 | 2018-08-25 | CISPLATIN + TEYSUNO | 01 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100678103 |
| 20215650 | 20175896 | 1.86 | 61.4 | null | 2020-07-29 | 2020-08-03 | IVA | 02 | null | NAB-PACLITAXEL | 100892795 |
| 20216542 | 20175898 | 1.52 | 75.5 | null | 2021-07-22 | 2021-08-08 | MIC | 02 | null | CARBO + FLUOROURACIL | 100867680 |
| 20217055 | 20175901 | 1.8 | null | Curative (C) | 2021-10-07 | 2021-11-25 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | NAB-PACLITAXEL | 101175464 |
| 20217411 | 20175902 | 1.61 | 78.85 | Palliative (P) | 2020-05-27 | 2020-05-29 | Atezolizumab | 01 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101264157 |
| 20217473 | 20175903 | 1.83 | 82 | null | 2021-10-18 | 2021-11-01 | Pertuzumab | null | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 101055865 |
| 20217550 | 20175904 | 1.54 | 75 | 03 | 2019-09-14 | 2019-12-14 | GemCarbo Days 1+8 | 02 | N | AVELUMAB + AXITINIB | 101585541 |
| 20217738 | 20175905 | 1.85 | 71 | null | 2017-05-27 | 2017-06-04 | Pemetrexed | 02 | null | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 101110137 |
| 20218161 | 20175906 | 1.65 | 96 | Neo-adjuvant (N) | 2019-09-24 | 2019-09-29 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CABAZITAXEL | 100382991 |
| 20220087 | 20175907 | 1.52 | 63.6 | Palliative (P) | 2018-06-26 | 2018-08-27 | Cisplatin + Docetaxel | N | null | HEPATOBLASTOMA SR PLADO | 100619517 |
| 20220308 | 20175908 | 1.82 | 76.6 | null | 2019-11-10 | 2022-02-06 | Gemcitabine + Paclitaxel | 02 | N | SCOPE2 TRIAL | 100517890 |
| 20220479 | 20175909 | 1.7 | 91.2 | Curative (C) | 2019-08-19 | 2020-04-03 | VINORELBINE | 02 | null | CHLVPP | 100467656 |
| 20221836 | 20175911 | 1.49 | 84.8 | null | 2017-10-29 | 2017-11-01 | Cabazitaxel | 02 | null | EOF | 101338877 |
| 20224442 | 20175912 | 1.77 | 106 | Palliative (P) | 2018-02-08 | 2018-09-27 | Bevacizumab + Oxaliplatin +MdG | 02 | N | NAB-PACLITAXEL | 101312033 |
| 20224829 | 20175913 | 1.65 | 67.15 | Palliative (P) | 2019-09-07 | 2019-09-10 | Bevacizumab + Oxaliplatin +MdG | N | N | GEMCARBO | 100465200 |
| 20018993 | 20175915 | 1.82 | 60.85 | null | 2021-12-17 | 2021-12-30 | Temozolomide + RT | 02 | null | ECF | 101406014 |
| 20021080 | 20175916 | 1.81 | 62.2 | null | 2020-02-29 | 2020-02-29 | ECF | 02 | null | TOPOTECAN | 100564750 |
| 20033541 | 20175918 | 1.51 | 7.8 | null | 2017-06-23 | 2017-06-24 | Carboplatin + Pemetrexed | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101695090 |
| 20035688 | 20175919 | 1.57 | 60.4 | Palliative (P) | 2018-07-12 | 2018-12-22 | Capecitabine + Streptozocin | N | Y | CYTARABINE + DAUNORUBICIN | 100982369 |
| 20039364 | 20175920 | 1.42 | 73 | null | 2021-01-19 | 2021-01-25 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | CAV | 101090148 |
| 20039998 | 20175921 | 1.56 | null | Adjuvant (A) | 2019-08-06 | 2019-08-06 | DARATUMUMAB | 02 | N | CYTARABINE | 101839329 |
| 20040304 | 20175922 | 1.66 | 118.2 | Palliative (P) | 2020-12-02 | 2020-12-21 | SCOPE 2 TRIAL | 02 | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100597632 |
| 20040612 | 20175923 | 1.54 | 107 | Palliative (P) | 2018-01-07 | 2018-03-18 | CISPLATIN + FLUOROURACIL + RT | 02 | null | PHITT C SIOPEL-3HR | 101227502 |
| 20046134 | 20175924 | 1.65 | 54.4 | null | 2017-08-10 | 2018-09-07 | POMALIDOMIDE | 02 | N | HYDROXYCARBAMIDE | 100443890 |
| 20049933 | 20175926 | 1.65 | 60.9 | null | 2019-04-20 | 2019-08-10 | MITOMYCIN | 02 | N | ECF | 100460285 |
| 20051858 | 20175927 | 1.82 | 90 | null | 2015-11-07 | 2017-11-08 | EOF | 02 | N | MIC | 101811196 |
| 20051949 | 20175928 | 1.81 | 12.1 | Curative (C) | 2021-11-15 | 2021-11-15 | BCG Intravesical | 02 | null | FCARBOST | 100930921 |
| 20054283 | 20175929 | null | 67 | null | 2017-04-22 | 2017-04-22 | Larotrectinib | 02 | null | ARISTOTLE TRIAL | 100040411 |
| 20058058 | 20175930 | 1.52 | 87 | Palliative (P) | null | 2019-10-29 | ARISTOTLE TRIAL | null | N | CARBOPLATIN + PEMETREXED | 100370115 |
| 20065210 | 20175932 | 1.55 | 53 | null | 2022-04-28 | 2022-04-29 | EOF | 02 | N | RITUXIMAB | 100023013 |
| 20065293 | 20175933 | 1.69 | 59.2 | Curative (C) | 2020-02-17 | 2020-02-24 | null | 02 | N | CABAZITAXEL | 100738854 |
| 20104742 | 20175934 | 1.61 | 65.3 | Curative (C) | 2022-04-10 | 2022-05-22 | CHOP R - 21 days | 02 | Y | IXAZOMIB + LENALIDOMIDE | 101354924 |
| 20112612 | 20175935 | 1.84 | 68.9 | 03 | 2018-10-21 | 2018-12-01 | ECarboF | 02 | N | EPIRUBICIN | 101479073 |
| 20112952 | 20175936 | 1.81 | 62 | null | 2017-12-25 | 2018-08-08 | Nintedanib | 02 | N | BINIMETINIB + ENCORAFENIB | 101726390 |
| 20199357 | 20175938 | 1.8 | 70.2 | Palliative (P) | 2019-08-30 | 2019-10-29 | Gemcitabine + Oxaliplatin | 02 | N | CISPLATIN + TEYSUNO | 100441603 |
| 20205619 | 20175939 | 1.65 | 80.9 | Curative (C) | 2019-08-29 | 2019-08-29 | Procarbazine | 02 | N | CAPE + CETUXIMAB + OXALIPLATIN | 101747743 |
| 20225316 | 20175941 | 1.56 | 133.2 | Curative (C) | 2018-04-30 | 2018-08-25 | PHITT D SIOPEL-4 (A1, A2, A3) | 01 | N | IRINOTECAN + RALTITREXED | 101453265 |
| 20046077 | 20175942 | null | 62.6 | Adjuvant (A) | 2020-12-04 | 2021-01-17 | Methotrexate intrathecal | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100829353 |
| 20070602 | 20175944 | 1.53 | 70 | Palliative (P) | 2021-11-30 | 2021-12-14 | R GDP | 02 | N | BENDAMUSTINE + RITUXIMAB | 101417571 |
| 20143202 | 20176917 | 1.78 | 57 | Adjuvant (A) | 2019-06-17 | 2019-06-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101372454 |
| 20143238 | 20176918 | 1.75 | 55.6 | Palliative (P) | 2020-07-14 | 2020-07-24 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101847699 |